(Q56404248)

English

The stability of mRNA encoding IL-4 is increased in pulmonary tuberculosis, while stability of mRNA encoding the antagonistic splice variant, IL-4δ2, is not

scholarly article by Keertan Dheda et al published May 2007 in Tuberculosis

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

0 references

The stability of mRNA encoding IL-4 is increased in pulmonary tuberculosis, while stability of mRNA encoding the antagonistic splice variant, IL-4δ2, is not (English)

0 references

1 reference

based on heuristic

inferred from title

pulmonary tuberculosis

1 reference

based on heuristic

inferred from title

object named as

Graham A.W. Rook

7

0 references

Alimuddin Zumla

object named as

Alimuddin Zumla

6

0 references

1

object named as

Keertan Dheda

0 references

author name string

Jung-Su Chang

2

0 references

Jim F. Huggett

3

0 references

Louise U. Kim

4

0 references

Margaret A. Johnson

5

0 references

publication date

May 2007

0 references

0 references

87

0 references

3

0 references

237-241

0 references

In vivo and in vitro studies of a novel cytokine, interleukin 4delta2, in pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.11.001

7 January 2021

T lymphocyte phenotypic profile in lung segments affected by cavitary and non-cavitary tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.11.001

7 January 2021

Pulmonary tuberculosis in BALB/c mice with non-functional IL-4 genes: changes in the inflammatory effects of TNF-alpha and in the regulation of fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.11.001

7 January 2021

Increased Interleukin-4 production by CD8 and gammadelta T cells in health-care workers is associated with the subsequent development of active tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.11.001

7 January 2021

Type 2 Cytokine Gene Activation and Its Relationship to Extent of Disease in Patients with Tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.11.001

7 January 2021

Increased production of interleukin 4 by CD4+ and CD8+ T cells from patients with tuberculosis is related to the presence of pulmonary cavities

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.11.001

7 January 2021

Immune responses to tuberculosis in developing countries: implications for new vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.11.001

7 January 2021

IL-4 in tuberculosis: implications for vaccine design

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.11.001

7 January 2021

Clinical and serological studies of tuberculosis patients in Argentina receiving immunotherapy with Mycobacterium vaccae (SRL 172)

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.11.001

7 January 2021

Healthy individuals that control a latent infection with Mycobacterium tuberculosis express high levels of Th1 cytokines and the IL-4 antagonist IL-4delta2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.11.001

7 January 2021

Do successful tuberculosis vaccines need to be immunoregulatory rather than merely Th1-boosting?

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.11.001

7 January 2021

Structural and functional properties of IL-4delta2, an alternative splice variant of human IL-4.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.11.001

7 January 2021

Expression of a novel cytokine, IL-4delta2, in HIV and HIV-tuberculosis co-infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.11.001

7 January 2021

Helicobacter pylori cagPathogenicity Island Is Associated with Reduced Expression of Interleukin-4 (IL-4) mRNA and Modulation of the IL-4δ2 mRNA Isoform in Human Gastric Mucosa

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.11.001

7 January 2021

Production of type 2 cytokines by CD8+ lung cells is associated with greater decline in pulmonary function in patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.11.001

7 January 2021

Acute cardiac transplant rejection is associated with low frequencies of interleukin-4 producing helper T-lymphocytes rather than with interleukin-4 promoter or splice variants

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.11.001

7 January 2021

Interleukin-4 and Its Alternatively Spliced Variant (IL-4 δ 2) in Patients with Atopic Asthma

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.11.001

7 January 2021

The usefulness of competitive PCR: airway gene expression of IL-5, IL-4, IL-4delta2, IL-2, and IFNgamma in asthma

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.11.001

7 January 2021

Validation of housekeeping genes for normalizing RNA expression in real-time PCR.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.11.001

7 January 2021

p38 Mitogen-activated protein kinase-dependent and -independent signaling of mRNA stability of AU-rich element-containing transcripts

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.11.001

7 January 2021

Interleukin-5 mRNA stability in human T cells is regulated differently than interleukin-2, interleukin-3, interleukin-4, granulocyte/macrophage colony-stimulating factor, and interferon-gamma

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.11.001

7 January 2021

Altered IL-4 mRNA stability correlates with Th1 and Th2 bias and susceptibility to hypersensitivity pneumonitis in two inbred strains of mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.11.001

7 January 2021

Suppression of the clinical and cytokine response to endotoxin by RWJ-67657, a p38 mitogen-activated protein-kinase inhibitor, in healthy human volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.11.001

7 January 2021

p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.11.001

7 January 2021

Identifiers

10.1016/J.TUBE.2006.11.001

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q56404248&oldid=2030965133"